Skip to Main Content

Paper Details

DNA methylation and cardiovascular disease in humans: a systematic review and database of known CpG methylation sites.
Clin Epigenetics
8
2023
19, CVD, Cardiovascular disease, CpG, CpG methylation sites, CpG sites, DNA, F2RL3, PTPRN2, Protein Tyrosine Phosphatase Receptor Type N2, TEA Domain Transcription Factor 1, TEAD1, Tyrosine, ZNF438, atherosclerosis, cardiac disease, cardiovascular disease, cg01656216, cg03636183, coronary heart disease, curated gene sets, cytosine, differentially methylated genes, gene, humans, mapped genes, myocardial infarction, platelet, vascular disease
Author NameAffiliation
Miguel A Andrade-NavarroInstitute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz
Philipp S WildUniversity Medical Center of the Johannes Gutenberg University Mainz
Philipp S WildInstitute of Molecular Biology (IMB)
Philipp S WildClinical Epidemiology and Systems Medicine, Center for Thrombosis and Hemostasis (CTH)
Philipp S WildGerman Center for Cardiovascular Research (DZHK), University Medical Center of the Johannes Gutenberg University Mainz
  • 1 - 5

Datasets

PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink